Thomas Andrew Crockett

KALV

Thomas Andrew Crockett serves as CEO at KalVista Pharmaceuticals, Inc. (KALV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

17 trades

$3.36M

Net Position

Net Seller

$3.36M

Companies Traded

KALV

Active Period

Apr 2021 – Feb 2024

17 total trades

Most Recent

Sell KALV

Feb 21, 2024 · $351.3K

Thomas Andrew Crockett's Insider Trading at KalVista Pharmaceuticals, Inc. (KALV)

Buys

0 · $0.00

Sells

17 · $3.36M

Total Shares Bought

Total Shares Sold

220,156

KALV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 21, 2024	Sell	24,888	$14.11	$351.3K	211,203
Feb 16, 2024	Sell	58,356	$15.01	$875.9K	181,676
Feb 5, 2024	Sell	10,000	$16.22	$162.2K	118,232
Dec 28, 2023	Sell	30,000	$12.02	$360.5K	127,532
Nov 21, 2023	Sell	14,807	$8.23	$121.9K	157,532
Aug 21, 2023	Sell	14,876	$10.73	$159.6K	146,756
May 19, 2023	Sell	5,627	$10.14	$57.1K	128,050
Feb 23, 2023	Sell	6,700	$7.66	$51.3K	120,927
Nov 21, 2022	Sell	1,785	$5.44	$9.7K	114,878
Sep 7, 2022	Sell	1,320	$17.01	$22.5K	110,858
Aug 19, 2022	Sell	1,797	$14.96	$26.9K	112,178
Mar 11, 2022	Sell	10,000	$17.07	$170.7K	114,670
Oct 4, 2021	Sell	10,000	$17.18	$171.8K	124,670
Jul 2, 2021	Sell	10,000	$24.15	$241.5K	140,320
Jun 22, 2021	Sell	1,067	$30.04	$32.1K	144,670
Jun 11, 2021	Sell	8,933	$30.05	$268.5K	145,737
Apr 5, 2021	Sell	10,000	$27.44	$274.4K	168,720